Anika Therapeutics Inc (ANIK)
25.57
-0.01
(-0.04%)
USD |
NASDAQ |
Apr 26, 16:00
25.58
+0.01
(+0.04%)
After-Hours: 20:00
Anika Therapeutics Revenue (Quarterly): 42.97M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 42.97M |
| September 30, 2023 | 41.46M |
| June 30, 2023 | 44.30M |
| March 31, 2023 | 37.92M |
| December 31, 2022 | 39.62M |
| September 30, 2022 | 40.26M |
| June 30, 2022 | 39.66M |
| March 31, 2022 | 36.69M |
| December 31, 2021 | 35.82M |
| September 30, 2021 | 39.54M |
| June 30, 2021 | 38.14M |
| March 31, 2021 | 34.29M |
| December 31, 2020 | 32.69M |
| September 30, 2020 | 31.69M |
| June 30, 2020 | 30.68M |
| March 31, 2020 | 35.40M |
| December 31, 2019 | 29.77M |
| September 30, 2019 | 29.70M |
| June 30, 2019 | 30.42M |
| March 31, 2019 | 24.72M |
| December 31, 2018 | 26.96M |
| September 30, 2018 | 26.79M |
| June 30, 2018 | 30.55M |
| March 31, 2018 | 21.26M |
| December 31, 2017 | 29.39M |
| Date | Value |
|---|---|
| September 30, 2017 | 27.18M |
| June 30, 2017 | 33.46M |
| March 31, 2017 | 23.39M |
| December 31, 2016 | 28.73M |
| September 30, 2016 | 25.79M |
| June 30, 2016 | 26.58M |
| March 31, 2016 | 22.28M |
| December 31, 2015 | 30.89M |
| September 30, 2015 | 23.68M |
| June 30, 2015 | 22.90M |
| March 31, 2015 | 15.52M |
| December 31, 2014 | 23.25M |
| September 30, 2014 | 22.06M |
| June 30, 2014 | 26.27M |
| March 31, 2014 | 34.01M |
| December 31, 2013 | 21.25M |
| September 30, 2013 | 17.75M |
| June 30, 2013 | 20.83M |
| March 31, 2013 | 15.25M |
| December 31, 2012 | 22.61M |
| September 30, 2012 | 14.77M |
| June 30, 2012 | 19.62M |
| March 31, 2012 | 14.36M |
| December 31, 2011 | 18.44M |
| September 30, 2011 | 18.46M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
29.70M
Minimum
Sep 2019
44.30M
Maximum
Jun 2023
36.37M
Average
36.69M
Median
Mar 2022
Revenue (Quarterly) Benchmarks
| The Cooper Companies Inc | 931.60M |
| Staar Surgical Co | 76.27M |
| OrthoPediatrics Corp | 37.61M |
| NexGel Inc | 1.082M |
| Innovative Eyewear Inc | 0.6158M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -63.00M |
| Total Expenses (Quarterly) | 44.56M |
| EPS Diluted (Quarterly) | -4.30 |
| Enterprise Value | 306.84M |
| Gross Profit Margin (Quarterly) | 61.27% |
| Profit Margin (Quarterly) | -146.6% |
| Earnings Yield | -22.10% |
| Normalized Earnings Yield | -22.10 |